Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Satellos Bioscience Inc (MSCLF)

Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Satellos Bioscience Inc 79 WELLINGTON STREET WEST 33RD FLOOR TORONTO A6 M5K 1N2 CAN

https://satellos.com P: 64-7660-1780

Description:

Satellos Bioscience Inc. is a regenerative medicine company dedicated to developing novel therapeutics which stimulate or restore muscle regeneration in severe disorders. The company's lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy. Satellos Bioscience Inc., formerly known as iCo Therapeutics Inc., is based in Toronto, Ontario.

Key Statistics

Overview:

Market Capitalization, $K 44,621
Enterprise Value, $K 28,271
Shares Outstanding, K 112,792
Annual Sales, $ 0 K
Annual Net Income, $ -11,770 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,120 K
EBIT, $ -17,290 K
EBITDA, $ -17,280 K
60-Month Beta 1.95
% of Insider Shareholders 37.90%
% of Institutional Shareholders 0.00%
Float, K 70,044
% Float 62.10%
Short Volume Ratio 0.76

Growth:

1-Year Return 3.75%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 65.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 05/14/24
Next Earnings Date 08/26/24
Earnings Per Share ttm -0.14
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -33.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MSCLF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -49.36%
Return-on-Assets % -45.73%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.95
Book Value/Share 0.23
Interest Coverage -89.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar